Dual REctcal Angiogenesis or MEK Inhibition radioTHERAPY Trial
Condition(s):Rectal CancerLast Updated:April 24, 2023Terminated
Hide Studies Not Open or Pending
Condition(s):Rectal CancerLast Updated:April 24, 2023Terminated
Condition(s):MelanomaLast Updated:March 14, 2016Completed
Condition(s):Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (Stage IIIB-IV)Last Updated:August 2, 2019Completed
Condition(s):Neurofibromatosis Type 1Last Updated:March 4, 2024Recruiting
Condition(s):Advanced Non Small Cell Lung CancerLast Updated:March 4, 2024Active, not recruiting
Condition(s):Non Small Cell Lung CarcinomaLast Updated:May 23, 2017Completed
Condition(s):Breast CancerLast Updated:September 3, 2020Terminated
Condition(s):Advanced CancerLast Updated:October 14, 2020Completed
Condition(s):Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell Lung; Carcinoma, ThymicLast Updated:April 11, 2023Active, not recruiting
Condition(s):Neurofibromatosis 1Last Updated:March 22, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.